INVE-B

Investor is a long-term owner of global companies, founded by the Wallenberg family in 1916. The company’s portfolio is organized into three business areas: Listed Companies, Patricia Industries, and Investments in EQT. Through significant ownership stakes and board representation, Investor supports its portfolio companies in achieving operational excellence and long-term value creation. The group holds interests in various industrial and consumer-facing businesses, including the Electrolux Professional Group, and maintains a strategic investment in the private equity firm EQT. Investor utilizes its industrial experience, network, and financial strength to assist its holdings in outperforming competition and reaching their full potential.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Asset Management Homepage investorab.com
Sector Financial Services IR page investorab.com
Tags
long-term investing, industrial holdings, board representation, portfolio management, private equity investment, corporate governance, Electrolux Professional Group, EQT, Patricia Industries, Wallenberg Investments
Press page —

Metrics

Valuation  
Market cap kr 1.275T
Market cap (USD) $ 125.528B
P/E 4.85
PEG —
P/BV 1.17
P/S 19.67
P/OCF 57.54
P/FCF —
Dividend yield 1.3%
Turnover / mcap —
Returns  
ROE 17.7%
ROI 14.7%
ROIC 15.1%
Profit margin 242.7%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 12.1%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 16
Quality score 55.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Revenue 64.826B 63.196B 59.643B 51.812B 40.737B 91.163B — — 34.381B 31.742B 25.365B 21.2B 18.569B 16.849B 14.674B 2.943B 381M
Net profit 157.34B 113.169B 126.817B -74.762B 227.965B 52.79B 101.226B -2.252B 44.318B 33.665B 17.433B 50.656B 45.165B 24.226B -9.229B 30.713B 31.379B

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Share price 285.53 370 233.5 188.6 227.8 — 127.8 — — — — — — — — — —
Price performance 12m -0.23 0.58 0.24 -0.17 0.52 — — — — — — — — — — — —

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (SEK) — 5.43B 5.72B 7.6B 7.98B 9.17B 9.07B
↳ YoY growth +5.4% +32.9% +5.0% +14.9% -1.1%
↳ 5y CAGR +10.8%
Other receivables (SEK) — 1.07B 2.13B 359M 411M 714M 304M
Borrowings, current (SEK) — 4.71B 3.26B 1.78B 4.61B 4.58B 1.43B
Borrowings, non-current (SEK) — 81.8B 84B 89.4B 84.5B 94.4B 114B
Cash and deposits (SEK) 19.2B 19.7B 18.3B 13.2B 18.8B 17.2B 14.1B
Intangible assets (SEK) — 28.4B 33.2B 34.4B 33.2B 33.7B 36.4B
Net debt (borrowings + leases - cash) (SEK) — 66.8B 68.9B 78.1B 70.3B 81.7B 102B
Cash flow detail
Operating cash flow (SEK) — 11B 14.3B 16.6B 21B 23.6B 22.2B
Dividends paid (cash effect) (SEK) — -6.89B -10.7B -12.3B -13.5B -14.7B -15.9B
Share buybacks (cash effect) (SEK) — -11M -149M -147M -226M -356M -198M
Interest paid (cash effect) (SEK) — -2.78B -2.4B -3.03B -3.5B -3.88B -6.05B
Income taxes paid (cash effect) (SEK) — -1.26B -1.44B -1.11B -1.41B -1.82B -1.97B
Income detail
Total comprehensive income (SEK) — 47.8B 232B -65.2B 125B 117B 150B
Comprehensive income to owners (SEK) — 48B 232B -65.2B 126B 117B 150B
Reported — — — — — — —

Operating KPIs — quarters

KPI Mar 25 Mar 26
Employees 8,725 8,320
↳ YoY growth -4.6%
Reported — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Investor hosts Capital Markets Update today Bull 0 Bear 0 Routine

At 13:00 CET today, Investor hosts a Capital Markets Update focusing on our strategy and our business areas.

Speakers include:
Christian Cederholm, CEO 
Jessica Häggström, Head of Human Resources 
Lovisa Cavalli Wallenberg, HR Business Partner & Analytics Wallenberg Investments
Jenny Ashman Haquinius, CFO 
Daniel Nodhäll, Head of Listed Companies 
Edward Flyborg, Head of Investments in EQT 
Thomas Kidane, Co-head Patricia Industries
Yuriy Prilutskiy, Co-head Patricia Industries
Brian LaDuke, CEO Sarnova
Scott Nelson, CEO BraunAbility
Chris Smith, CEO Laborie
Byron Selman, CEO Nova Biomedical
Guillaume Joucla, CEO Mölnlycke

To participate in the live webcast, please register here .
 

Downloads

Investor hosts Capital Markets Update today

_Our press releases can be accessed at www.investorab.com _

Investor AB, founded by the Wallenberg family in 1916, creates value for people and society by building strong and sustainable companies. Through substantial ownership and board participation, we drive initiatives that we believe create value and support our companies to remain or become best-in-class. Our portfolio is organized in three business areas: Listed Companies, Patricia Industries and Investments in EQT.

New leaders appointed for Mölnlycke Health Care Bull 0 Bear 0 Management

Mölnlycke announces the appointment of Anders Andersson as Chief Executive Officer (CEO) of Mölnlycke Health Care and Fredrik Wallefors as President of Surgical, effective January 1, 2027. 
 

“Anders Andersson and Fredrik Wallefors both have the experience and drive needed to successfully lead our business into the future, maintaining our commitment to patients, healthcare professionals and customers.” says Karl-Henrik Sundström, Chair of the Board of Directors at Mölnlycke.
 

“We are pleased to see the appointment of two internal candidates as the new leaders of Mölnlycke. Anders and Fredrik are highly experienced leaders with deep knowledge of their respective businesses and a clear ambition to drive continued profitable growth.” says Thomas Kidane, Co-Head Patricia Industries.
 

As announced on September 16, 2026, Mölnlycke intends to separate into two standalone companies under Patricia Industries’ ownership during 2027. From January 1, 2027, Anders Andersson will assume the CEO responsibilities of Mölnlycke Health Care and Fredrik Wallefors will be President of Surgical. The intention is that Fredrik Wallefors will assume the position of CEO of Mölnlycke Surgical, if and when the separation and relevant consultations with employee representatives are completed. Guillaume Joucla will continue to serve as interim CEO of Mölnlycke Health Care until the end of 2026.

Downloads

New leaders appointed for Mölnlycke Health Care

_Our press releases can be accessed at www.investorab.com _

Investor AB, founded by the Wallenberg family in 1916, creates value for people and society by building strong and sustainable companies. Through substantial ownership and board participation, we drive initiatives that we believe create value and support our companies to remain or become best-in-class. Our portfolio is organized in three business areas: Listed Companies, Patricia Industries and Investments in EQT.

The Board of Atlas Antibodies and Dan Pitulia have mutually agreed that Dan will leave his position as the CEO of the Atlas Antibodies Group.
 

Morten Henneveld has assumed the role of interim CEO as of November 1, 2026. Morten was most recently CEO of OssDsign and prior to that held leadership positions at GN Group, Zimmer Biomet and Coloplast.
 

“We thank Dan for his leadership, and we look forward to partnering with Morten and the team as we embark on the next chapter together. His extensive leadership experience and track record of driving strategic change will be instrumental in the company’s continued development”, says Åsa Riisberg, Chair of Atlas Antibodies.
 

“We are pleased to welcome Morten to Atlas Antibodies and look forward to working with him. We thank Dan for his valuable contributions”, says Thomas Kidane, Co-Head of Patricia Industries. 

Downloads

Morten Henneveld appointed interim CEO of Atlas Antibodies

_Our press releases can be accessed at www.investorab.com _

Investor AB, founded by the Wallenberg family in 1916, creates value for people and society by building strong and sustainable companies. Through substantial ownership and board participation, we drive initiatives that we believe create value and support our companies to remain or become best-in-class. Our portfolio is organized in three business areas: Listed Companies, Patricia Industries and Investments in EQT.

Prompts

Investor (ticker INVE-B), listed in Sweden.

ETFs Holding Investor

ETF Weight in ETF Shares Market value As of
IVSI 2.05% 3,911 $ 162.368K Jun 30, 2026
FFDI 1.95% 8,766 $ 378.361K Jul 31, 2026
FFGX 1.37% 17,257 $ 744.852K Jul 31, 2026
FEOE 1.27% 562,125 $ 24.245M Aug 31, 2026
FEGE 0.96% 560,649 $ 24.182M Aug 31, 2026
GMOI 0.79% 126,375 $ 5.451M Aug 31, 2026
FENI 0.68% 1,685,625 $ 69.98M Jun 30, 2026
DWMF 0.58% 4,784 $ 198.984K Jun 30, 2026
TIER 0.31% 2,538 $ 109.636K Jul 31, 2026
GEW 0.24% 7,905 $ 340.956K Aug 31, 2026
RINT 0.14% 4,746 $ 197.033K Jun 30, 2026
RGLO 0.07% 6,073 $ 252.124K Jun 30, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
INVE-A Common share A SE nordic 407.98 SEK 2026-10-20
INVE-B canonical Common share B SE nordic 415.59 SEK 2026-10-20